These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33305919)

  • 61. Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort'' by Mastrolia
    Borocco C; Pouletty M; Galeotti C; Meinzer U; Faye A; Koné-Paut I; Ouldali N; Melki I
    Ann Rheum Dis; 2022 Nov; 81(11):e219. PubMed ID: 33023959
    [No Abstract]   [Full Text] [Related]  

  • 62. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
    Sokolovsky S; Soni P; Hoffman T; Kahn P; Scheers-Masters J
    Am J Emerg Med; 2021 Jan; 39():253.e1-253.e2. PubMed ID: 32631771
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical Usefulness of T-Cell Receptor Vβ Repertoire Analysis for Differentiating Multisystem Inflammatory Syndrome in Japanese Children From Toxic Shock Syndrome and Kawasaki Disease.
    Kaneko S; Noguchi Y; Hatano M; Shimbo A; Irabu H; Furuno K; Iwata N; Fujimura J; Akamine K; Kobayashi A; Endo T; Morio T; Shimizu M
    Pediatr Infect Dis J; 2024 Apr; 43(4):e125-e127. PubMed ID: 38134372
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Purple eyelid sign in multisystem inflammatory syndrome in children.
    Komatsu Y; Nozawa T; Kamiyama Y; Hattori S; Nishimura K; Ito S
    Pediatr Int; 2023; 65(1):e15510. PubMed ID: 36802119
    [No Abstract]   [Full Text] [Related]  

  • 65. Kawasaki Shock Syndrome and Covid-19.
    Ashraf S; Abbasi FS; Atiq M
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):135-137. PubMed ID: 34271815
    [TBL] [Abstract][Full Text] [Related]  

  • 66. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise.
    Schroeder AR; Wilson KM; Ralston SL
    Hosp Pediatr; 2020 Oct; 10(10):e1-e3. PubMed ID: 32404331
    [No Abstract]   [Full Text] [Related]  

  • 67. Cutaneous manifestations of COVID-19.
    Wang CJ; Worswick S
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paediatric inflammatory multisystem syndrome: What should we look out for in South Africa?
    Hendricks CL; Mustafa F; Green RJ; Pepper MS
    S Afr Med J; 2020 Aug; 110(9):832-834. PubMed ID: 32880261
    [No Abstract]   [Full Text] [Related]  

  • 69. Pulsed methylprednisolone for multisystem inflammatory syndrome in a Japanese boy.
    Okada T; Akashi M; Oku T; Shinabe Y; Yokota I
    Pediatr Int; 2022 Jan; 64(1):e15303. PubMed ID: 36329655
    [No Abstract]   [Full Text] [Related]  

  • 70. A case of multisystem inflammatory syndrome in an African adolescent male: case report.
    Moodley P; Tsitsi JML; Reddy DL; Debising M; Ickinger C
    Pan Afr Med J; 2021; 38():174. PubMed ID: 33995781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Kawasaki disease].
    Avilés C; Guerrero J; Lueg E; Spalloni P; Toro C
    Rev Chil Pediatr; 1987; 58(6):462-7. PubMed ID: 3506215
    [No Abstract]   [Full Text] [Related]  

  • 72. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
    Shaigany S; Gnirke M; Guttmann A; Chong H; Meehan S; Raabe V; Louie E; Solitar B; Femia A
    Lancet; 2020 Jul; 396(10246):e8-e10. PubMed ID: 32659211
    [No Abstract]   [Full Text] [Related]  

  • 73. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit.
    Yagnam R F; Izquierdo C G; Villena M R; González M C; Drago-T M
    Andes Pediatr; 2021 Jun; 92(3):395-405. PubMed ID: 34479246
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recommendations for the initial management of multisystem inflammatory syndrome temporally related to COVID-19, in children and adolescents.
    Kohn-Loncarica G; Fustiñana A; Díaz-Rubio F; Jaramillo-Bustamante JC; González-Dambrauskas S; Vásquez-Hoyos P; Fernández-Sarmiento J; González G; Mansur A; Ponce J; Jabornisky R
    Arch Argent Pediatr; 2020 Dec; 118(6):e514-e526. PubMed ID: 33231054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multisystem Inflammatory Disease in Children During the First Year of the COVID-19 Pandemic.
    Evans SM; Harris-Kober S; Kamboj A; Stankovic C; DeLaroche AM
    Clin Pediatr (Phila); 2022 Feb; 61(2):127-132. PubMed ID: 34875895
    [No Abstract]   [Full Text] [Related]  

  • 76. Multisystem Inflammatory Syndrome With Pericardial Tamponade in COVID-19: A Case Report.
    Jamee A; Abotaima Z; Muammar I
    Clin Pediatr (Phila); 2022 Feb; 61(2):112-115. PubMed ID: 34541927
    [No Abstract]   [Full Text] [Related]  

  • 77. Pathophysiological and clinical point of view on Kawasaki disease and MIS-C.
    Vaňková L; Bufka J; Křížková V
    Pediatr Neonatol; 2023 Sep; 64(5):495-504. PubMed ID: 37453902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Update on SARS-CoV-2 infection in children.
    Martins MM; Prata-Barbosa A; da Cunha AJLA
    Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hoarseness as a presenting sign in children with Kawasaki disease.
    Leuin SC; Shanbhag S; Lago D; Sato Y; Sun X; Jain S; Burns JC; Tremoulet AH
    Pediatr Infect Dis J; 2013 Dec; 32(12):1392-4. PubMed ID: 23811742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute covid-19 and multisystem inflammatory syndrome in children.
    Rubens JH; Akindele NP; Tschudy MM; Sick-Samuels AC
    BMJ; 2021 Mar; 372():n385. PubMed ID: 33648933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.